fda cleared immunoassay semaglutide assay Approval vs Compounded Alternatives Semaglutide sodium salt - BOC

This is everything you need to know about weight loss + weight maintenance on and after GLP-1 drugs

Robust GIP Affinity: Optimized to drive complex lipid buffering and cellular homeostasis studies

On September 19, 2025, the FDA issued Import Alert 66-80, which authorizes field staff to detain without physical examination shipments of GLP-1 active On September 19, 2025, the FDA issued Import Alert 66-80, which authorizes field staff to detain without physical examination shipments of GLP-1 active pharmaceutical ingredients (APIs) from manufacturers not included on its newly established "Green List.

Once daily high dose oral semaglutide is associated with reductions in body weight in overweight adults without type 2 diabetes and reductions in body weight an...